Other
AstraZeneca's £19bn blow as Wainua heart drug fails key late-stage trial
P
Proactive Investors
Published: Jul 09, 2026, 07:50 AM
Sentiment Analysis
Bearish0.20
BEARISHNEUTRALBULLISH
AstraZeneca's £19bn blow as Wainua heart drug fails key late-stage trial
Sponsored
Source: Proactive Investors
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.